Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Posted in Product Liability

Bloomberg News (6/18, Feeley) reported, “Pfizer Inc. faces a Texas trial over its hormone-replacement drugs after a court overseeing lawsuits over the medicines sent 200 cases back to their home courts.”

At issue in the suit is whether “the Prempro [conjugated estrogens and medroxyprogesterone] menopause drug helped cause” the plaintiff’s breast cancer.

Over “8,000 lawsuits over the medicine consolidated in federal court in Arkansas” will be “returned for trial.” Still, “Pfizer…has won dismissals of more than 3,000 cases at either the pretrial stage or after the cases have been set for trials.”

Read full story here.

Continue reading

A Florida couple who fled their dream home because of foul-smelling, ruinous Chinese drywall was awarded $2.4 million in damages in the nation’s first jury trial over the defective wallboard that could have legal ramifications for thousands of similar cases.

The defendant, drywall distributor Banner Supply, is named in thousands of other lawsuits. Associated Press, The Washington Post 06/21/2010
Read Article: The Washington Post

Continue reading

Merck & Co. lost the second trial to reach a verdict over claims its osteoporosis drug Fosamax causes so-called jaw death. The jury set damages at $8 million.

A jury in New York ruled against Merck today in the case of Shirley Boles, 72, of Fort Walton Beach, Florida. Boles claimed she developed osteonecrosis of the jaw, or ONJ, from taking Fosamax. The first Fosamax case resulted in a Merck victory in May.

Recently a link has been found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw (ONJ aka. Dead Jaw). This important discovery clearly shows that Fosamax side effects may include osteonecrosis of the jaw, aka, dead jaw or jaw death as well as osteomyelitis of the jaw. Fosamax has also been linked to low energy femur fractures (thigh bone fractures).

The case is Boles v. Merck & Co., 06-cv-09455, and the lawsuits are combined in In Re Fosamax Products Liability Litigation, MDL 1789, U.S. District Court, Southern District of New York (Manhattan).

Read full Bloomberg story here.

Continue reading

Camden County, Penn., has agreed to a $15 million settlement with a man who lost his leg and part of his arm when his car crashed into a guardrail and the railing snapped off, cutting through the vehicle.

In 2004, Nicholas Anderson was driving on Raritan Road when he was forced off the road by an oncoming car.

The lawsuit claims that the guardrail was improperly designed and should have absorbed the impact of Anderson’s vehicle instead of snapping off.

Properly designed guardrails were later installed throughout the county. Barbara Boyer , Philadelphia Inquirer 06/18/2010
Read Article: Philadelphia Inquirer

Continue reading

The Legal Intelligencer (6/23, Elliott-Engel) reports, “Drugmaker GlaxoSmithKline has agreed to settle almost 200 cases in which plaintiffs allege the use of the antidepressant Paxil caused birth defects.”

GSK “decided to settle Kilker v. SmithKline Beecham Corp. d/b/a GlaxoSmithKline along with another 190 cases, according to an order signed by Philadelphia Common Pleas Judge Sandra Mazer Moss last week.” Jamie Sheller, “local plaintiffs liaison counsel for the Paxil pregnancy mass tort program,” estimated “that up to another 100 cases, including cases that have not yet been filed, have settled.”

Read the full story here.

Continue reading

The AP (6/4) reported, “A former physician-owner and two former employees at a Las Vegas-area colonoscopy clinic were indicted on 28 felony charges, including racketeering, negligence and insurance fraud stemming from a 2008 hepatitis C outbreak.

A judge in Las Vegas issued arrest warrants for physician Dipak Desai and former Endoscopy Center of Southern Nevada anesthetists Ronald Ernest Lakeman and Keith Mathahs on charges resulting from allegations they misused syringes and clinic instruments to transmit the incurable liver disease to seven patients.”

Read the full story here.

Continue reading

The National Law Journal (6/11, Bronstad) reports, “Dozens of sudden-acceleration lawsuits filed against Toyota Motor Corp. in California’s state courts will be coordinated in Los Angeles.

California Chief Justice Ronald George issued an order to that effect on Tuesday, following a hearing on May 21 when Los Angeles County, Calif., Superior Court Judge Carl West coordinated at least 21 lawsuits into a single proceeding.”

Read the full story here.

Continue reading

The Wall Street Journal (6/11, B4, Whalen, Mundy) reports that David Graham, an FDA drug-safety official argues in a new study that the diabetes drug Avandia (rosiglitazone) may have led to thousands of heart problems that could have been prevented if patients had been using a different medication.

The agency is already scheduled next month to evaluate the Avandia’s safety. Graham, along with other experts, has said that drug should be removed from the market.

Read the full story here.

Continue reading

Federal officials investigating Johnson & Johnson over the massive recall of children’s medicine earlier this year have said that the drug maker is stalling their investigation.

New York Rep. Edolphus Towns said that J&J has provided the Congressional committee false information and is being much less cooperative than other companies facing similar investigations.

Towns cited several actions by J&J to downplay the recall and hide the medicine defects, calling them disturbing trends within the company. Investigators say that if J&J continues to show a lack of cooperation, more severe actions, such as the issuing of subpoenas and criminal charges, could come next.

Natasha Singer, The New York Times 06/10/2010
Read Article: The New York Times

Continue reading

More than 5,400 battery packs used in some automated external defibrillators have been recalled due to a defect.

The recalled was issued by the FDA because the batteries had the potential to falsely detect an error condition during charging for a shock and then cancel the charge.

The batteries were used in defibrillators manufactured by Defibtech LLC. and were distributed worldwide to fire departments, emergency medical service units, health clubs, schools and other organizations. Staff Report, United Press International 06/09/2010
Read Article: United Press International

Continue reading

Contact Information